pharma · Colitis, Ulcerative · Multiple Myeloma
Janssen Cilag International
Janssen Cilag International NV
Janssen Cilag International clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- São Paulo, EU
- Employees
- 13
- Programs
- 46
- Drugs
- 37
- Patents
- 0
Janssen Cilag International projects
21 ClinicalTrials.gov programs sponsored by Janssen Cilag International.
Janssen Cilag International has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Amivantamab
Janssen Cilag International NV
Colorectal Neoplasms
1 trial -
Apalutamide
Janssen Cilag International NV
Metastatic Castrate-sensitive Prostate Cancer
1 trial -
Canagliflozin
Janssen Cilag International NV
Diabetes Mellitus, Type 2
1 trial -
Cilta-cel
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Dara SC
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Daratumumab
Janssen Cilag International NV
Multiple Myeloma
3 trials -
Esketamine
Janssen Cilag International NV
Depressive Disorder, Major
1 trial -
Glimepiride
Janssen Cilag International NV
Diabetes Mellitus, Type 2
1 trial -
Golimumab 1 mg per kg
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
Guselkumab Dose 1
Janssen Cilag International NV
Crohn's Disease
1 trial -
Ibrutinib
Janssen Cilag International NV
Chronic Lymphocytic Leukemia
1 trial -
Icotrokinra
Janssen Cilag International NV
Crohn Disease
1 trial -
JNJ-77242113
Janssen Cilag International NV
Plaque Psoriasis
1 trial -
LHRHa
Janssen Cilag International NV
Prostatic Neoplasms
1 trial -
Nipocalimab
Janssen Cilag International NV
Sjogrens Syndrome
1 trial -
Olanzapine
Janssen Cilag International NV
Bipolar Disorder
1 trial -
Paliperidone palmitate
Janssen Cilag International NV
Schizophrenia
2 trials -
Pimodivir 600 mg
Janssen Cilag International NV
Influenza A
1 trial -
Rituximab
Janssen Cilag International NV
Chronic Lymphocytic Leukemia
1 trial -
Tapentadol IR 50 mg
Janssen Cilag International NV
Hallux Valgus
1 trial -
Ustekinumab Dose Based on BSA and Body Weight
Janssen Cilag International NV
Colitis, Ulcerative
1 trial
Frequently asked questions
How many clinical projects does Janssen Cilag International have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.